An indictment was returned today by a federal grand jury in New Jersey, charging the former chief executive officer of a publicly-traded health care company (referred to in the indictment as Company-1) with two counts of securities fraud for his alleged participation in a scheme to mislead investors about Company-1’s procurement of COVID-19 rapid test kits in the early days of the COVID-19 pandemic.

Department of Justice

Date Range

Report Type

Report Category

Submitting Agency

State/Local Agency

State (State and Local Reports)

Fraud Type

Agency Reviewed

Related Organizations

Management Challenges

Any Recommendations

Any Open Recommendations

Reports

Brooklyn Company Sentenced for Price Gouging KN95 Masks During COVID-19 Pandemic

Florida Man Charged with $1.6 Million Cares Act Loan Fraud Scheme

Somerset County Man Sentenced to 46 Months in Prison for Orchestrating COVID-19 Fraud

Camden County Man Admits Defrauding COVID-19 Relief Programs and Illegally Possessing Firearm

Six People Charged with Fraudulently Obtaining Loans Meant To Help Small Businesses During COVID-19 Pandemic

Camden County Woman Admits Fraudulently Obtaining 30 Loans Meant to Help Small Businesses During COVID-19 Pandemic

Former Warren County Businessman Admits Fraudulently Obtaining $1.8 Million in COVID-19 Loans Meant for Small Businesses

Burlington County Businessman Admits Defrauding Over 75 Victims of More Than $2.7 Million in Scheme to Sell Pesticides He Claimed Would Kill Coronavirus

Former CEO Indicted for Misleading Investors about COVID-19 Rapid Test Kits

Pennsylvania Man Charged with $1.7 Million Paycheck Protection Program Loan Fraud Scheme

Glossary

Glossary name will go here